Xilingyuan Pharmaceutical

company

About

Xilingyuan Pharmaceutical is a generic drug and innovative drug developer.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
¥90M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Aug 2, 2016
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥90M
Xilingyuan Pharmaceutical has raised a total of ¥90M in funding over 2 rounds. Their latest funding was raised on Nov 25, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 25, 2022 Series B ¥90M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Xilingyuan Pharmaceutical is funded by 2 investors. Chengdu Hi-tech Investment Group and Chengdu Biocity are the most recent investors.
Investor Name Lead Investor Funding Round
Chengdu Hi-tech Investment Group Series B
Chengdu Biocity Series B